Anon. (1967). EEC Council Directive 67/548/EEC on the approximation of the laws, regulations and administrative provisions relating to the classification, packaging and labelling of dangerous substances. Official Journal of the European Communities196, 1–98.
2.
Anon. (1999). Directive 1999/45/EC of the European Parliament and of the Council of 31 May 1999 concerning the approximation of the laws, regulation and administrative provisions of the Member States relating to the classification, packaging and labelling of dangerous preparations. Official Journal of the European CommunitiesL200, 1–68.
3.
Anon. (2006). Regulation (EC) No 1907/2006 of the European Parliament and of the Council of 18 December 2006 concerning the Registration, Evaluation, Authorisation and Restriction of Chemicals (REACH), establishing a European Chemicals Agency, amending Directive 1999/45/EC and repealing Council Regulation (EEC) No 793/93 and Commission Regulation (EC) No 1488/94 as well as Council Directive 76/769/EEC and Commission Directives 91/155/EEC, 93/67/EEC, 93/105/EC and 2000/21/EC.Official Journal of the European UnionL396, 1–849. Available at: http://eur-lex.europa.eu/LexUriServ/site/en/oj/2006/l_396/l_39620061230en00010849.pdf (Accessed 14.04.08).
4.
MagnussonB. & KligmanA.M. (1970). Allergic Contact Dermatitis in the Guinea Pig, 141pp. Spring field, IL, USA:Charles C. Thomas.
5.
BuehlerE.V. (1965). Delayed contact hypersensitivity in the guinea pig. Archives of Dermatology91, 171–177.
6.
KimberI. & BasketterD.A. (1992). The murine local lymph node assay; collaborative studies and new directions: A commentary. Food & Chemical Toxicology30, 165–169.
7.
Anon. (1999). The Murine Local Lymph Node Assay: A Test Method for Assessing the Allergic Contact Dermatitis Potential of Chemicals/Compounds. The Results of an Independent Peer Review Evaluation Coordinated by the Interagency Coordinating Committee on the Validation of Alternative Methods (ICCVAM) and the National Toxicology Program Center for the Evaluation of Alternative Toxicological Methods (NICEATM). NIH Publication 99-4494, 211pp. Research Triangle Park, NC, USA:National Toxicology Program. Available at: http://iccvam.niehs.nih.gov/docs/immunotox_docs/llna/llnarep.pdf (Accessed 14.04.08).
8.
BallsM. & HellstenE. (2000). Statement on the validity of the local lymph node assay for skin sensitisation testing. ATLA28, 366–367.
9.
GerberickG.F., RyanC.A., KimberI., DearmanR.J., LeaL.J. & BasketterD.A. (2000). Local lymph node assay validation assessment for regulatory purposes. American Journal of Contact Dermatitis11, 3–18.
10.
DeanJ.H., TwerdokL.E., TiceR.R., SailstadD.M., HattanD.G. & StokesW.S. (2001). ICCVAM evaluation of the murine local lymph node assay. II. Conclusions and recommendations of an independent scientific peer review panel. Regulatory Toxicology & Pharmacology34, 258–273.
11.
WahlbergJ.E. & BomanA. (1985). Guinea pig maximization test. In Contact Allergy Predictive Tests in Guinea Pigs: Current Problems in Dermatology (ed. MaibachH.I. & AndersonK.E.), pp. 59–106. New York, NY, USA:S. Karger.
12.
CroninM.T.D. & BasketterD.A. (1994). Multivariate QSAR analysis of a skin sensitisation database. SAR & QSAR in Environmental Research2, 159–179.
13.
BasketterD.A. & GerberickG.F. (1996). Interlaboratory evaluation of the Buehler test. Contact Dermatitis35, 146–151.
14.
Anon. (1992). Council Directive 92/32/EEC of 30 April 1992 amending for the seventh time Directive 67/548/EEC on the approximation of the laws, regulations and administrative provisions relating to the classification, packaging and labelling of dangerous substances. Official Journal of the European CommunitiesL154, 1–29.
15.
Anon. (2001). Commission Directive 2001/59/EC of 6 August 2001 adapting to technical progress for the 28th time Council Directive 67/548/EEC on the approximation of the laws, regulations and administrative provisions relating to the classification, packaging and labelling of dangerous substances (Text with EEA relevance). Official Journal of the European CommunitiesL225, 1–333.
16.
BasketterD.A., AndersenK.E., LidénC., van LoverenH., BomanA., KimberI., AlankoK. & BerggrenE. (2005). Evaluation of the skin sensitising potency of chemicals using existing methods and considerations of relevance for elicitation. Contact Dermatitis52, 39–43.
17.
KimberI., BasketterD.A., ButlerM., GamerA., GarrigueJ.L., NewsomeC., SteilingW. & VohrH-W. (2003). Classification of allergens according to potency: proposals. Food & Chemical Toxicology41, 1799–1809.
18.
WHO (1997). Criteria for classification of skin and airway sensitizing substances in the work and general environments. Doc. No. EUR/ICP/EHPM 05 02 01(P), 111pp. Copenhagen, Denmark:World Health Organisation, Regional Office for Europe.
19.
BasketterD.A., GerberickF. & KimberI. (2007). The local lymph node assay and the assessment of relative potency: status of validation. Contact Dermatitis57, 70–75.
20.
FelterS.P., RyanC.A., BasketterD.A., GilmourN.J. & GerberickG.F. (2003). Application of the risk assessment paradigm to the induction of allergic contact dermatitis. Regulatory Toxicology & Pharmacology37, 1–10.
JowseyI., BasketterD.A., WestmorelandC. & KimberI. (2006). A future approach to measuring relative skin sensitising potency. Journal of Applied Toxicology26, 341–350.
23.
GerberickG.F., RyanC.A., KernP.S., SchlatterH., DearmanR.J., KimberI., PatlewiczG. & BasketterD.A. (2005). Compilation of historical local lymph node assay data for the evaluation of skin sensitisation alternatives. Dermatitis16, 157–202.
24.
GerberickG.F., VassalloJ.D., BaileyR.E., ChaneyJ.G., MorrallS.W. & LepoittevinJ.P. (2004). Development of a peptide reactivity assay for screening contact allergens. Toxicological Sciences81, 332–343.
25.
GerberickG.F., VassalloJ.D., FoertschL.M., PriceB.B., ChaneyJ.G. & LepoittevinJ.P. (2007). Quantification of chemical peptide reactivity for screening contact allergens: A classification tree model approach. Toxicological Sciences97, 417–427.
26.
AptulaA.O., PatlewiczG., RobertsD.W. & SchultzT.W. (2006). Non-enzymatic glutathione reactivity and in vitro toxicity: a non-animal approach to skin sensitisation. Toxicology in Vitro20, 239–247.
27.
RobertsD.W. & WilliamsD.L. (1982). The derivation of quantitative correlations between skin sensitisation and physico–chemical parameters for alkylating agents and their application to experimental data for sultones. Journal of Theoretical Biology99, 807–825.
28.
PatelwiczG., AptulaA.O., UriarteE., RobertsD.W., KernP.S., GerberickG.F., KimberI., DearmanR.J., RyanC.A. & BasketterD.A. (2007). An evaluation of selected global (Q)SARs/expert systems for the prediction of skin sensitisation potential. SAR & QSAR in Environmental Research18, 515–541.
DearmanR.J. & KimberI. (2003). Factors influencing the induction phase of skin sensitisation. American Journal of Contact Dermatitis14, 188–194.
31.
KissenpfennigA. & MalissenB. (2006). Langerhans cells — revisiting the paradigm using genetically engineered mice. Trends in Immunology27, 132–139.
32.
KimberI., CumberbatchM., DearmanR.J., BhushanM. & GriffithsC.E.M. (2000). Cytokines and chemokines in the initiation and regulation of epidermal Langerhans cell mobilization. British Journal of Dermatology142, 401–412.
33.
KimberI. & CumberbatchM. (1992). Dendritic cells and cutaneous immune responses to chemical allergens. Toxicology & Applied Pharmacology117, 137–146.
34.
KimberI., DearmanR.J., CumberbatchM. & HubyR.J.D. (1998). Langerhans cells and chemical allergy. Current Opinion in Immunology10, 614–619.
35.
CumberbatchM., DearmanR.J., AntonopoulosC., GrovesR.W. & KimberI. (2001). Interleukin (IL)-18 induces Langerhans cell migration by a tumour necrosis factor-α and IL-1β-dependent mechanism. Immunology102, 323–330.
36.
WangB., FelicianiC., HowellB.G., FreedI., CaiQ., WatanabeH. & SauderD. (2002). Contribution of Langerhans cell-derived IL-18 to contact hyper-sensitivity. Journal of Immunology168, 3303–3308.
37.
RyanC.A., GerberickG.F., GildeaL.A., HuletteB.C., BettsC.J., CumberbatchM., DearmanR.J. & KimberI. (2005). Interactions of contact allergens with dendritic cells: opportunities and challenges for the development of novel approaches to hazard assessment. Toxicological Sciences88, 4–11.
38.
GriffithsC.E.M., DearmanR.J., CumberbatchM. & KimberI. (2005). Cytokines and Langerhans cell mobilisation in mouse and man. Cytokine32, 67–70.
LandsteinerK. & JacobsJ. (1936). Studies on the sensitisation of animals with simple chemical compounds. Journal of Experimental Medicine64, 625–639.
41.
DupuisG. & BenezraC. (1982). Allergic Contact Dermatitis to Simple Chemicals: A Molecular Approach, 200pp. New York, NY, USA & Basel, Switzerland:Marcel Dekker.
42.
DarleyM.O., PostW. & MunterR.L. (1977). Induction of cell-mediated immunity to chemically modified antigens in guinea pigs. Journal of Immunology118, 963–970.
43.
FriersonM.R., KlopmanG. & RosenkranzH.S. (1986). Structure–activity relationships among mutagens and carcinogens: A review. Environmental Mutagenesis8, 283–327.
44.
GuengerichF.P. & LieblerD.C. (1985). Enzymatic activation of chemicals. CRC Critical Reviews in Toxicology14, 259–307.
45.
MeansG.E. & FeeneyR.E. (1971). Chemical Modification of Proteins, 254pp. San Francisco, CA, USA:Holden Day.
46.
RomagnoliP., LabahrdtA.M. & SinigagliaF. (1991). Selective interaction of nickel with an MHC bound peptide. The EMBO Journal10, 1303–1306.
47.
LepoittevinJ-P. & BenezraC. (1992). 13C-enriched methyl alkanesulfonates: New lipophilic methylating agents for the identification of nucleophilic amino acids of proteins by NMR. Tetrahedron Letters33, 3875–3878.
48.
FranotC., BenezraC. & LepoittevinJ-P. (1993). Synthesis and interaction studies of 13C labeled lactone derivatives with a model protein using 13C NMR. Bioorganic & Medicinal Chemistry1, 389–397.
49.
MeschkatE., BarrattM.D. & LepoittevinJ-P. (2001). Studies of the chemical selectivity of hapten, reactivity, and skin sensitisation potency. 1: Synthesis and studies on the reactivity toward model nucleophiles of the 13C-labeled skin sensitizers hex-1-ene- and hexane-1,3-sultones. Chemical Research in Toxicology14, 110–117.
50.
MeschkatE., BarrattM.D. & LepoittevinJ-P. (2001). Studies of the chemical selectivity of hapten, reactivity, and skin sensitisation potency. 2: NMR studies of the covalent binding of the 13C-labeled skin sensitizers 2-[13C]- and 3-[13C]hex-1-ene- and 3-[13C]hexane-1,3-sultones to human serum albumin. Chemical Research in Toxicology14, 118–126.
51.
Alvarez-SanchezR., BasketterD.A., PeaseC. & LepoittevinJ-P. (2003). Studies of chemical selectivity of hapten, reactivity and skin sensitisation potency. 3: Synthesis and studies on the reactivity towards model nucleophiles of the 13C-labeled skin sensitizers, 5-chloro-2-methylisothiazol-3-one (MCI) and 2-methylisothiazol-3-one (MI). Chemical Research in Toxicology16, 627–636.
52.
Alvarez-SanchezR., BasketterD.A., PeaseC. & LepoittevinJ-P. (2004). Covalent binding of the 13C-labeled skin sensitizers 5-chloro-2-methylisothiazol-3-one (MCI) and 2-methylisothiazol-3-one (MI) to a model peptide and glutathione. Bioorganic Medicinal Chemistry Letters14, 365–368.
53.
Alvarez-SanchezR., DivkovicM., BasketterD.A., PeaseC., PanicoM., DellA., MorrisH. & LepoittevinJ-P. (2004). Effect of glutathione on the covalent binding of the 13C-labelled skin sensitizer 5-chloro-2-methylisothiazol-3-one (MCI) to human serum albumin: identification of adducts by NMR, MALDI–MS and nano-ES–MS/MS. Chemical Research in Toxicology17, 1280–1288.
54.
BarrattM.D. & BasketterD.A. (1992). Possible origin of the skin sensitization potential of eugenol and related compounds. Contact Dermatitis27, 98–104.
55.
Giménez-ArnauE., HaberkornL., GrossiL. & LepoittevinJ-P. (2002). Identification of alkyl radicals derived from an allergenic cyclic tertiary allylic hydroperoxide by combined use of radical trapping and ESR studies. Tetrahedron58, 5535–5545.
56.
BézardM., Gimenez-ArnauE., MeurerB., GrossiL. & LepoittevinJ.P. (2005). Identification by radical trapping and EPR studies of carbon-centered radicals derived from linalyl hydroperoxide, a strong skin sensitizer: a possible route for protein modifications. Bioorganic Medicinal Chemistry13, 3977–3986.
57.
PayneM.P. & WalshP.T. (1994). Structure–activity relationships for skin sensitisation potential: development of structural alerts for use in knowledge based toxicity prediction systems. Journal of Chemical Information & Computer Sciences34, 154–161.
58.
BarrattM.D., BasketterD.A., ChamberlainM., PayneM.P., AdmansG.D. & LangowskiJ.J. (1994). An expert system rulebase for identifying contact allergens. Toxicology in Vitro8, 1053–1060.
59.
AshbyJ., BasketterD.A., PatonD. & KimberI. (1995). Structure–activity relationships in skin sensitisation using the murine local lymph node assay. Toxicology103, 177–194.
60.
RobertsD.W. & BasketterD.A. (1997). Further evaluation of the quantitative structure–activity relationship for skin-sensitizing alkyl transfer agents. Contact Dermatitis37, 107–112.
61.
RobertsD.W., YorkM. & BasketterD.A. (1999). Structure–activity relationships in the murine local lymph node assay for skin sensitisation: α,β-diketones. Contact Dermatitis41, 14–17.
62.
GernerI., BarrattM.D., ZinkeS., SchlegelK. & SchledeE. (2004). Development and prevalidation of a list of structure–activity relationship rules to be used in expert systems for prediction of the skin sensitizing properties of chemicals. ATLA32, 487–509.
BashirS.J. & MaibachH.I. (1999). Quantitative structure analysis relationships in the prediction of skin sensitisation potential. In Biochemical Modulation of Skin Reactions: Transdermals, Topicals, Cosmetics (ed. KydonieusA.F. & WilleJ.J.), pp. 61–64. New York, NY, USA:CRC Press.
65.
RodfordR., PatlewiczG., WalkerJ.D. & PayneM.P. (2003). Quantitative structure–activity relationships for predicting skin and respiratory sensitisation. Environmental Toxicology & Chemistry22, 1855–1861.
66.
RobertsD.W. (1987). Structure–activity relationships for skin sensitisation potential of diacrylates and dimethacrylates. Contact Dermatitis17, 281–289.
67.
RobertsD.W. & BenezraC. (1993). Quantitative structure–activity relationships for skin sensitisation potential of urushiol analogues. Contact Dermatitis29, 78–83.
68.
AptulaA.O., PatlewiczG. & RobertsD.W. (2005). Skin sensitisation: Reaction mechanistic applicability domains for structure–activity relationships. Chemical Research in Toxicology18, 1420–1426.
69.
AptulaA.O. & RobertsD.W. (2006). Mechanistic applicability domains for nonanimal-based prediction of toxicological end points: General principles and application to reactive toxicity. Chemical Research in Toxicology19, 1097–1105.
70.
LiY., TsengY.J., PanD., LiuJ., KernP.S., GerberickG.F. & HopfingerA.J. (2007). 4D-finger-print categorical QSAR models for skin sensitisation based on the classification of local lymph node assay measures. Chemical Research in Toxicology20, 114–128.
71.
MageeP.S., HostynekJ.J. & MaibachM.I. (1994). A classification model for allergic contact dermatitis. Quantitative Structure–Activity Relationships13, 22–33.
72.
FedorowiczA., SinghH., SoderholmS. & DemchukE. (2005). Structure–activity models for contact sensitization. Chemical Research in Toxicology18, 954–969.
73.
EstradaE., PatlewiczG., ChamberlainM., BasketterD. & LarbeyS. (2003). Computer-aided knowledge generation for understanding skin sensitisation mechanisms: The TOPS-MODE approach. Chemical Research in Toxicology16, 1226–1235.
74.
LepoittevinJ-P. (2006). Metabolism versus chemical transformation or pro- versus prehaptens?Contact Dermatitis54, 73–74.
75.
SmithC.K. & HotchkissS.A.M. (2001). Allergic Contact Dermatitis: Chemical and Metabolic Mechanisms, 310pp. London, UK:Taylor and Francis.
76.
MabicS., CastagnoliK. & CastagnoliN. (1999). Oxidative metabolic bioactivation of xenobiotics. In Handbook of Drug Metabolism (ed. WoolfT.F.), pp. 49–79. New York, NY, USA:Marcel Dekker.
77.
KalgutkarA.S., GardnerI., ObachR.S., ShafferC.L., CallegariE., HenneK.R., MutlibA.E., DalvieD.K., LeeJ.S., NakaiY., O'DonnellJ.P., BoerJ. & HarrimanS.P. (2005). A comprehensive listing of bioactivation pathways of organic functional groups. Current Drug Metabolism6, 161–225.
78.
GuengerichF.P. (2005). Principles of covalent binding of reactive metabolites and examples of activation of bis-electrophiles by conjugation. Archives of Biochemistry & Biophysics433, 369–378.
79.
SmithC.K., MooreC.A., ElahiE.N., SmartA.T. & HotchkissS.A. (2000). Human skin absorption and metabolism of the contact allergens, cinnamic aldehyde, and cinnamic alcohol. Toxicology & Applied Pharmacology168, 189–199.
80.
CheungC., HotchkissS.A. & PeaseC.K. (2003). Cinnamic compound metabolism in human skin and the role metabolism may play in determining relative sensitisation potency. Journal of Dermatological Science31, 9–19.
81.
ElahiE.N., WrightZ., HinselwoodD., HotchkissS.A., BasketterD.A. & PeaseC.K. (2004). Protein binding and metabolism influence the relative skin sensitisation potential of cinnamic compounds. Chemical Research in Toxicology17, 301–310.
82.
NilssonA.M., BergstromM.A., LuthmanK., NilssonJ.L. & KarlbergA.T. (2005). A conjugated diene identified as a prohapten: contact allergenic activity and chemical reactivity of proposed epoxide metabolites. Chemical Research in Toxicology18, 308–316.
83.
BergstromM.A., LuthmanK., NilssonJ.L. & KarlbergA.T. (2006). Conjugated dienes as prohaptens in contact allergy: in vivo and in vitro studies of structure–activity relationships, sensitizing capacity, and metabolic activation. Chemical Research in Toxicology19, 760–769.
84.
BergstromM.A., OttH., CarlssonA., NeisM., Zwadlo-KlarwasserG., JonssonC.A., MerkH.F., KarlbergA.T. & BaronJ.M. (2007). A skin-like cytochrome P450 cocktail activates prohaptens to contact allergenic metabolites. The Journal of Investigative Dermatology127, 1145–1153.
85.
BergstromM.A., LuthmanK. & KarlbergA.T. (2007). Metabolic epoxidation of an alpha, beta-unsaturated oxime generates sensitizers of extreme potency. Are nitroso intermediates responsible?Chemical Research in Toxicology20, 927–936.
86.
GoetzG., MeschkatE. & LepoittevinJ.P. (1999). Synthesis of a water-soluble analog of 6-methyl-3-N-alkyl catechol labeled with carbon 13: NMR approach to the reactivity of poison ivy/oak sensitizers toward proteins. Bioorganic Medicinal Chemistry Letters9, 1141–1146.
87.
WhiteJ.M., KullavanijayaP., DuangdeedenI., ZazzeroniR., GilmourN.J., BasketterD.A. & McFaddenJ.P. (2006). p-Phenylenediamine allergy: the role of Bandrowski's base. Clinical & Experimental Allergy36, 1289–1293.
88.
BasketterD.A. & GoodwinB.F. (1988). Investigation of the prohapten concept. Cross reactions between 1,4-substituted benzene derivatives in the guinea pig. Contact Dermatitis19, 248–253.
89.
CoulterE.M., FarrellJ., MathewsK.L., MaggsJ.L., PeaseC.K., LockleyD.J., BasketterD.A., ParkB.K. & NaisbittD.J. (2007). Activation of human dendritic cells by p-phenylenediamine. Journal of Pharmacology & Experimental Therapeutics320, 885–892.
90.
BertrandF., BasketterD.A., RobertsD.W. & LepoittevinJ.P. (1997). Skin sensitisation to eugenol and isoeugenol in mice: possible metabolic pathways involving ortho-quinone and quinone methide intermediates. Chemical Research in Toxicology10, 335–343.
91.
NaisbittD.J. (2004). Drug hypersensitivity reactions in skin: understanding mechanisms and the development of diagnostic and predictive tests. Toxicology194, 179–196.
92.
IsakssonM., BruzeM., GoossensA. & LepoittevinJ-P. (2000). Patch-testing with serial dilutions of tixocortol pivalate and potential cross-reactive substances. Acta Dermato Venereologica80, 33–38.
93.
SjöborgS., FregertS. & TrulssonL. (1984). Contact allergy to styrene and related chemicals. Contact Dermatitis10, 94–96.
94.
KimberI., HiltonJ., DearmanR.J., GerberickG.F., RyanC.A., BasketterD.A., LeaL., HouseR.V., LadicsG.S., LovelessS.E. & HastingsK.L. (1998). Assessment of the skin sensitisation potential of topical medicaments using the local lymph node assay: an interlaboratory evaluation. Journal of Toxicology & Environmental Health53, 563–579.
95.
SköldM., BörjeA., MaturaM. & KarlbergA.T. (2002). Studies on the autoxidation and sensitizing capacity of the fragrance chemical linalool, identifying a linalool hydroperoxide. Contact Dermatitis46, 267–272.
96.
SköldM., BörjeA., HarambasicE. & KarlbergA.T. (2004). Contact allergens formed on air exposure of linalool. Identification and quantification of primary and secondary oxidation products and the effect on skin sensitisation. Chemical Research in Toxicology17, 1697–1705.
97.
KarlbergA.T. (1988). Contact allergy to colophony. Chemical identifications of allergens, sensitisation experiments and clinical experiences. Acta Dermato Venereologica139, 1–43.
98.
KarlbergA.T. (2000). Colophony. In Handbook of Occupational Dermatology (ed. KanervaL., ElsnerP., WahlbergJ.E. & MaibachH.I.), pp. 509–516. Heidelberg, Germany:Springer-Verlag.
99.
KarlbergA.T., BohlinderK., BomanA., HacksellU., HermanssonJ., JacobssonS. & NilssonJ.L. (1988). Identification of 15-hydroperoxyabietic acid as a contact allergen in Portuguese colophony. Journal of Pharmacy & Pharmacology40, 42–47.
100.
Brared-ChristenssonJ., MaturaM., BacktorpC., BörjeA., NilssonJ.L.G. & KarlbergA.T. (2006). Hydroperoxides form specific antigens in contact allergy. Contact Dermatitis55, 230–237.
101.
KarlbergA.T. & Dooms-GoossensA. (1997). Contact allergy to oxidized d-limonene among dermatitis patients. Contact Dermatitis36, 201–206.
102.
MaturaM., GoossensA., BordaloO., Garcia-BravoB., MagnussonK., WrangsjoK. & KarlbergA.T. (2002). Oxidized citrus oil (R-limonene): a frequent skin sensitizer in Europe. Journal of the American Academy of Dermatology47, 709–714.
MaturaM., SköldM., BörjeA., AndersenK.E., BruzeM., FroschP., GoossensA., JohansenJ.D., SvedmanC., WhiteI.R. & KarlbergA.T. (2006). Not only oxidized R-(+)- but also S-(–)-limonene is a common cause of contact allergy in dermatitis patients in Europe. Contact Dermatitis55, 274–279.
105.
WillisI. & KligmanA.M. (1968). The mechanism of photoallergic contact dermatitis. Journal of Investigative Dermatology51, 378.
106.
HarberL.C. & BickersD.R. (1989). Photosensitivity Disease: Principles of Diagnosis and Treatment, 442pp. Philadelphia, PA, USA:W.B. Saunders.
107.
SchidtR.J. & KingstonT. (1984). Testing with musk ambrette and congeners in a case of photosensitivity dermatitis and actinic reticuloid syndrome (PD/AR). Photodermatology1, 195–198.
108.
BakerB.S. (2005). The role of microorganisms in atopic dermatitis. Clinical & Experimental Immunology Review144, 1–9.
109.
KatoH., OkamotoM., YamashitaK., NakamuraY., FukumoriY., NakaiK. & KanekoH. (2003). Peptide-binding assessment using mass spectrometry as a new screening method for skin sensitisation. Journal of Toxicological Sciences28, 19–24.
110.
AhlforsS.R., SternerO. & HanssonC. (2003). Reactivity of contact allergenic haptens to amino acid residues in a model carrier peptide, and characterization of formed peptide–hapten adducts. Skin Pharmacology & Applied Skin Physiology16, 59–68.
111.
NatschA., GfellerH., RothauptM. & EllisG. (2007). Utility and limitations of a peptide reactivity assay to predict fragrance allergensin vitro. Toxicology in Vitro21, 1220–1226.
112.
AebyP., GriemP., GerberickF. & GoebelC. (2007). Development and preliminary evaluation of a monoclonal antibody based assay for detecting protein reactive chemicals. The Toxicologist96, 248.
113.
SchultzT.W., YarbroughJ.W. & JohnsonE.L. (2005). Structure–activity relationships for reactivity of carbonyl-containing compounds with glutathione. SAR & QSAR in Environmental Research16, 313–322.
114.
RobertsD.W., GoodwinB.F., WilliamsD.L., JonesK., JohnsonA.W. & AldersonJ.C. (1983). Correlations between skin sensitisation potential and chemical reactivity for p-nitrobenzyl compounds. Food & Chemical Toxicology21, 811–813.
115.
FranotC., RobertsD.W., SmithR.G., BasketterD.A., BenezraC. & LepoittevinJ-P. (1994). Structure–activity relationships for contact allergenic potential of gamma, gamma-dimethyl-gammabutyrolactone derivatives. 1: Synthesis and electrophilic reactivity studies of alpha-(omega-substituted-alkyl)-gamma, gamma-dimethyl-gamma-butyrolactones and correlation of skin sensitisation potential and cross-sensitisation patterns with structure. Chemical Research in Toxicology7, 297–306.
116.
FranotC., RobertsD.W., BasketterD.A. & BenezraC. (1994). Structure–activity relationships for contact allergenic potential of gamma, gamma-dimethyl-gamma-butyrolactone derivatives. 2: Quantitative structure–skin sensitisation relationships for alpha-substituted-alpha-methyl-gamma, gamma-dimethyl-gamma-butyrolactones. Chemical Research in Toxicology7, 307–312.
117.
HansonC., AhlforsS. & SternerO. (1999). Reactivities of contact allergenic quinones towards a model peptide and identification of the adducts. Journal of Investigative Dermatology113, 320–320.
118.
TraceyB.M. & ShukerD.E. (1997). Characterization of azo coupling adducts of benzenediazonium ions with aromatic amino acids in peptides and proteins. Chemical Research in Toxicology10, 1378–1386.
119.
Conduah BirtJ.E., ShukerD.E. & FarmerP.B. (1998). Stable acetaldehyde–protein adducts as bio-markers of alcohol exposure. Chemical Research in Toxicology11, 136–142.
120.
FabriziL., TaylorG.W., CanasB., BoobisA.R. & EdwardsR.J. (2003). Adduction of the chloroform metabolite phosgene to lysine residues of human histone H2B. Chemical Research in Toxicology16, 266–275.
121.
BakerA., ZidekL., WieslerD., ChmelikJ., PagelM. & NovotnyM.V. (1998). Reaction of N-acetyl-glycyllysine methyl ester with 2-alkenals: an alternative model for covalent modification of proteins. Chemical Research in Toxicology11, 730–740.
122.
CelisJ.E., OstergaardM., JensenN.A., GromovaI., RasmussenH.H. & GromovP. (1998). Human and mouse proteomic databases: novel resources in the protein universe. FEBS Letters430, 64–72.
123.
HopkinsJ.E., NaisbittD.J., KitteringhamN.R., DearmanR.J., KimberI. & ParkB.K. (2005). Selective haptenation of cellular or extracellular protein by chemical allergens: association with cytokine polarization. Chemical Research in Toxicology18, 375–381.
124.
DennehyM.K., RichardsK.A., WernkeG.R., ShyrY. & LieblerD.C. (2006). Cytosolic and nuclear protein targets of thiol-reactive electrophiles. Chemical Research in Toxicology19, 20–29.
125.
ShinN.Y., LiuQ., StamerS.L. & LieblerD.C. (2007). Protein targets of reactive electrophiles in human liver microsomes. Chemical Research in Toxicology20, 859–867.
126.
AleksicM., PeaseC.K., BasketterD.A., PanicoM., MorrisH.R. & DellA. (2007). Investigating protein haptenation mechanisms of skin sensitisers using human serum albumin as a model protein. Toxicology in Vitro21, 723–733.
127.
JacquoilleotS., ThainE., ZazzeroniR. & AleksicM. (2007). Covalent modification of model peptides: Peptide reactivity testing strategies. Abstract 578 in Proceedings of the 55th ASMS Conference on Mass Spectrometry and Allied Topics.Santa Fe, NM, USA:American Society for Mass Spectrometry.
128.
HagvallL., BacktorpC., SvenssonS., NymanG., BorjeA. & KarlbergA.T. (2007). Fragrance compound geraniol forms contact allergens on air exposure. Identification and quantification of oxidation products and effect on skin sensitization. Chemical Research in Toxicology20, 807–814.
129.
ZhengJ., MaL., XinB., OlahT., HumphreysW.G. & ZhuM. (2007). Screening and identification of GSH-trapped reactive metabolites using hybrid triple quadruple linear ion trap mass spectrometry. Chemical Research in Toxicology, 20, 757–766.
130.
TroutmanJ., GerberickF., FoertschL., QuijanoM., DobsonR. & LepoittevinJ-P. (2007). Method optimization of a peroxidase peptide reactivity assay for screening the skin sensitisation potential of prohaptens. The Toxicologist96, 248.